Weiss, Anna
Grossmith, Samantha
Cutts, Danielle
Mikami, Sage A.
Suskin, Johanna A.
Graichen, Mary Knust
Rojas, Negui Arilis
Pace, Lydia E.
Joyce, Eileen
Rhei, Esther
Scheib, Rochelle
Bychkovsky, Brittany
Garber, Judy E.
Morganstern, Daniel
King, Tari A. http://orcid.org/0000-0003-3602-2351
Funding for this research was provided by:
Susan G. Komen (Susan G. Komen)
Article History
Received: 18 December 2018
Accepted: 20 December 2018
First Online: 21 January 2019
Compliance with ethical standards
:
: JA Suskin reports stock ownership in Pfizer, Thermo Fisher, and Danaher (owned by immediate family members). JE Garber reports a consultant/advisory role for Helix Genetics. TA King reports a consultant/advisory role for Genomic Health. None of these affiliations influenced this work. All other authors report no conflicts.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: The study was approved by the Brigham and Women’s Hospital Institutional Review Board as a low risk study and approved with waiver of consent.